Free Review Articles on HDL                                 Metatextbook

Freie Reviews über HDL                                 Look here for Journal Homepages




  • HDL
  • LDL
  • LXR
  • CETP
  • Apolipoprotein AI
  • Endothelial lipase
  • Doxazosin
  • Regeneration of tissues and other biologic structures
  • ABCA1
  • Niacin
  • Receptor (Pregnane X Receptor)
  • ABCG1
  • Acute phase reaction
  • Sphingosine1 phosphate
  • Thrombosis (BASKET)
  • Statin
  • Rosuvastatin
  • Simvastatin
  • Atorvastatin
  • Atherosclerosis (peripheral vessels)
  • Phospholipid transfer protein
  • Paraoxonase1
  • Serum Amyloid A
  • Inflammation (BASKET)
  • Lipoprotein associated phospholipase A2
  • sPLA2
  • Receptor (Scavenger)
  • Receptor (S1P)
  • Antigen presentation and processing
  • Nr.Year

    OPEN

    Titleusers

    say

    rate

    good

    rate

    bad

    no link

    Citation
    12008High-density lipoproteins: the next frontier in lipid management.



    +-nlMed J Aust 189(8):421-2 (2008)
    22007Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets.



    +-nlHeart 93(5):559-64 (2007)
    32008High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.



    +-nlVasc Health Risk Manag 4(1):39-57 (2008)
    42005Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.



    +-nlVasc Health Risk Manag 1(2):119-29 (2005)
    52006Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.



    +-nlPharmacol Rev 58(3):342-74 (2006)
    62008HDL-C as a new paradigm in atherosclerotic diseases.



    +-nlIndian J Physiol Pharmacol 52(4):319-26 (2008)
    72006High-density lipoproteins: an emerging target in the prevention of cardiovascular disease.



    +-nlCell Res 16(10):799-808 (2006)
    82009Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications.



    +-nlBMB Rep 42(7):393-400 (2009)
    92008High-density lipoprotein: does it have a dark side?



    +-nlArthritis Res Ther 10(5):121 (2008)
    102008Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.



    +-nlArthritis Res Ther 10(4):213 (2008)
    112001Oxidized LDL and HDL: antagonists in atherothrombosis.



    +-nlFASEB J 15(12):2073-84 (2001)
    122007The structure of apolipoprotein A-I in high density lipoproteins.



    +-nlJ Biol Chem 282(31):22249-53 (2007)
    132006Assembly of high-density lipoprotein.



    +-nlArterioscler Thromb Vasc Biol 26(1):20-7 (2006)
    142004High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.



    +-nlArterioscler Thromb Vasc Biol 24(3):387-91 (2004) Brewer HB Jr
    152003Endothelial protection by high-density lipoproteins: from bench to bedside.



    +-nlArterioscler Thromb Vasc Biol 23(10):1724-31 (2003)
    162004Antiinflammatory properties of HDL.



    +-nlCirc Res 95(8):764-72 (2004)
    172003Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data.



    +-nlDiabetes Metab 29(3):201-5 (2003)
    182006Molecular regulation of HDL metabolism and function: implications for novel therapies.



    +-nlJ Clin Invest 116(12):3090-100 (2006)
    191990Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.



    +-nlJ Clin Invest 86(2):379-84 (1990)
    202007HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects.



    +-nlJ Lipid Res 48(11):2325-33 (2007)
    212006Thematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans?



    +-nlJ Lipid Res 47(8):1631-42 (2006)
    222004The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.



    +-nlJ Lipid Res 45(6):993-1007 (2004)
    231999High density lipoprotein receptors, binding proteins, and ligands.



    +-nlJ Lipid Res 40(2):187-201 (1999)
    241984Synthesis, transport, and processing of apolipoproteins of high density lipoproteins.



    +-nlJ Lipid Res 25(13):1586-92 (1984)
    251984Sites and mechanisms of uptake and degradation of high density and low density lipoproteins.



    +-nlJ Lipid Res 25(13):1577-85 (1984)
    261984High density lipoprotein metabolism.



    +-nlJ Lipid Res 25(10):1017-58 (1984)
    272007High-density lipoprotein as a therapeutic target: a systematic review.



    +-nlJAMA 298(7):786-98 (2007)
    282009From menace to marvel: high-density lipoprotein prevents endothelial nitric oxide synthase uncoupling in diabetes mellitus by angiotensin II type 1 receptor downregulation.



    +-nlHypertension 53(4):587-9 (2009)
    292006Liver X receptor activation and high-density lipoprotein biology: a reversal of fortune?



    +-nlCirculation 113(1):5-8 (2006) Lee CH
    302010The complexity of high-density lipoproteins.



    +-nlCirculation 122(19):1900-1 (2010)
    312005Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians.



    +-nlCirculation 111(14):1847-54 (2005)
    322011Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins.



    +-nlCirc J 75(7):1533-8 (2011)
    332010Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis.



    +-nlCirc J 74(11):2263-70 (2010)
    342007Old drug, new tricks: the unexpected effect of doxazosin on high-density lipoprotein.



    +-nlCirc Res 101(2):116-8 (2007) Remaley AT
    352005New insights into the regulation of HDL metabolism and reverse cholesterol transport.



    +-nlCirc Res 96(12):1221-32 (2005)
    362006Endothelial and antithrombotic actions of HDL.



    +-nlCirc Res 98(11):1352-64 (2006)
    372010High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome.



    +-nlArterioscler Thromb Vasc Biol 30(8):1497-9 (2010) Getz GS
    382006A new dimension in the vasculoprotective function of HDL: progenitor-mediated endothelium repair.



    +-nlArterioscler Thromb Vasc Biol 26(5):965-7 (2006) Lesnik P
    392004Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease.



    +-nlArterioscler Thromb Vasc Biol 24(10):1755-60 (2004)
    402008Antiinflammatory actions of HDL: a new insight.



    +-nlArterioscler Thromb Vasc Biol 28(11):1890-1 (2008) Rye KA
    412008Of mice and men: blowing away the cobwebs from the mechanism of action of niacin on HDL metabolism.



    +-nlArterioscler Thromb Vasc Biol 28(11):1892-5 (2008) Watts GF
    422010Structure and function of HDL mimetics.



    +-nlArterioscler Thromb Vasc Biol 30(2):164-8 (2010)
    432010Dysfunctional HDL as a diagnostic and therapeutic target.



    +-nlArterioscler Thromb Vasc Biol 30(2):151-5 (2010)
    442005A role for the pregnane X receptor in high-density lipoprotein metabolism.



    +-nlArterioscler Thromb Vasc Biol 25(10):2016-7 (2005) Shelness GS
    452005Cardioprotective effects of high-density lipoproteins: the evidence strengthens.



    +-nlArterioscler Thromb Vasc Biol 25(7):1305-6 (2005) Barter PJ
    462009The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis.



    +-nlArterioscler Thromb Vasc Biol 29(11):1718-22 (2009)
    472010Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.



    +-nlArterioscler Thromb Vasc Biol 30(2):139-43 (2010)
    482006Understanding changes in high density lipoproteins during the acute phase response.



    +-nlArterioscler Thromb Vasc Biol 26(8):1687-8 (2006) Van Lenten BJ
    492009Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection.



    +-nlCardiovasc Res 82(2):201-11 (2009)
    502008High-density lipoprotein mass, cholesteryl ester transport protein, and macrophage reverse cholesterol transport: from the bedside back to the bench.



    +-nlCardiovasc Res 77(4):614-5 (2008) Levy Y
    512002The role of high density lipoproteins in thrombosis.



    +-nlScientificWorldJournal 2(-):89-95 (2002)
    522005Strategies to promote HDL-C: an emerging therapeutic target.



    +-nlEur Heart J 26(9):853-5 (2005)
    532010Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database.



    +-nlJ Lipid Res 51(6):1546-53 (2010)
    542010Genetic causes of high and low serum HDL-cholesterol.



    +-nlJ Lipid Res 51(8):2032-57 (2010)
    552010The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?



    +-nlJ Lipid Res 51(8):2058-73 (2010)
    562009The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis.



    +-nlJ Lipid Res 50 Suppl(-):S201-6 (2009)
    572009The metabolism and anti-atherogenic properties of HDL.



    +-nlJ Lipid Res 50 Suppl(-):S195-200 (2009)
    582005Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?



    +-nlJ Lipid Res 46(3):389-403 (2005)
    592009The role of dysfunctional HDL in atherosclerosis.



    +-nlJ Lipid Res 50 Suppl(-):S145-9 (2009)
    602009Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma.



    +-nlJ Clin Endocrinol Metab 94(4):1081-3 (2009) Fazio S
    612009Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I.



    +-nlEndocr J 56(3):317-34 (2009)
    622008Laboratory assessment of HDL heterogeneity and function.



    +-nlClin Chem 54(5):788-800 (2008)
    632007Therapies for raising high-density lipoprotein cholesterol.



    +-nlIntern Med 46(7):339-40 (2007)
    642006High-density lipoproteins: metabolic, clinical, epidemiological and therapeutic intervention aspects. An update for clinicians.



    +-nlArq Bras Cardiol 87(5):671-9 (2006)
    652006HDL management: recent advances and perspectives beyond LDL reduction.



    +-nlArq Bras Cardiol 87(6):788-94 (2006)
    662010Increasing high-density lipoprotein as a therapeutic target in atherothrombotic disease.



    +-nlRev Esp Cardiol 63(3):323-33 (2010)
    672010High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.



    +-nlClin Exp Immunol 160(2):137-42 (2010)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.